responses – Page 69 – Communicable Diseases Research

Impact of the COVID-19 Pandemic on the Mental Health of Healthcare Workers

Article

Published on 2021-02-032022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, MERS,

Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients

중증 COVID-19 환자의 SARS-CoV-2에 대한 세포 면역 손상

Immunology

Published on 2021-02-022022-09-12
Journal: Frontiers in Immunology [Category] MERS, 진단,

[키워드] acute infection acute phase acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome Adaptive immune response Adaptive immunity antibody Antibody Response ARDS CD4 CD8 cellular cellular immunity convalescent individual coronavirus COVID-19 COVID-19 patient develop exhibited expression healthy controls Hospitalization humoral immune responses IFNγ Impaired individual infection rate interferon gamma MOST mounted Neutralization antibody Neutralizing antibodies NK cell pandemic percentage Peripheral blood peripheral blood lymphocyte producing reduced responses SARS-CoV-2 severe COVID-19 patient Severe patient severe patients shown significantly Spread Symptoms syndrome T cell T cells Viral proteins virus
[DOI] 10.3389/fimmu.2021.603563 PMC 바로가기 [Article Type] Immunology

Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries

Research Article

Published on 2021-02-022022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS,

CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections

Review

Published on 2021-02-012022-10-04
Journal: Drug development research [Category] SARS, 신약개발,

Vi-specific serological correlates of protection for typhoid fever

비특이적 장티푸스 예방을 위한 혈清학적 상관관계

Article

Published on 2021-02-012022-10-29
Journal: The Journal of Experimental Medicine [Category] COVID-19, 살모넬라증,

T cell and antibody responses to SARS-CoV-2: Experience from a French transplantation and hemodialysis center during the COVID-19 pandemic

SARS-CoV-2에 대한 T 세포 및 항체 반응: COVID-19 전염병 동안 프랑스 이식 및 혈액 투석 센터의 경험

Article

Published on 2021-02-012022-09-11
Journal: American journal of transplantation : official jou [Category] MERS, 바이오마커, 진단,

[키워드] Adaptive immune response antibody Antibody Response Antibody responses Antiviral COVID-19 COVID-19 diagnosis COVID-19 pandemic COVID-19 patient differential diagnosis evaluate experience exposure to form French healthy control Hemodialysis immune response immune responses Immunity immunobiology Immunosuppressed immunosuppressive immunosuppressive therapy Infection infection and infectious agents - viral infectious agent infectious agents involved kidney kidney transplantation / nephrology monitoring: immune Nephrology Patient progression reactivity reduction Research responses risk RT-PCR SARS-CoV-2 serological seronegative severe forms of COVID-19 T cell T cell response T cell responses T cells the disease therapy translational translational research / science. Transplant virus
[DOI] 10.1111/ajt.16348 PMC 바로가기 [Article Type] Article

Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates

COVID-19 회복기 혈장 기증자 후보 중 SARS-CoV-2에 대한 중화 항체의 임상, 실험실 및 시간 예측인자

Clinical Trial

Published on 2021-02-012022-09-12
Journal: The Journal of Clinical Investigation [Category] MERS, 임상, 진단,

[키워드] 95% CI adaptive Adaptive immunity adjusted administration of plasma age Analysis antibody AOR assays candidate clinical collected convalescent individual convalescent plasma correlated COVID-19 Cutoff declined disease disease severity Donor Factor Fever Frederick Hospitalization immune immunoglobulins individual Infectious disease Laboratory laboratory assay Male sex median NAb neutralizing antibody New NIAID NIH Older age plasma Predictive predictor proportion PROTECT receiver operating characteristic Reinfection responses S1 domain SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection SARS-CoV-2 spike protein SARS-CoV-2-neutralizing antibody seronegative seropositive serum IgG severity Sex Society specimen Streamline Support supported symptom onset T cell tested transplantation treatment for COVID-19 Virology with COVID-19
[DOI] 10.1172/JCI144930 PMC 바로가기 [Article Type] Clinical Trial

Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review

Review

Published on 2021-01-292022-10-28
Journal: Vaccines [Category] COVID-19,

Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration

SARS-CoV-2 회복기 동안 감지된 전환 및 전환되지 않은 메모리 B 세포는 제한된 증상 지속 기간과 상관 관계가 있습니다

Research Article

Published on 2021-01-282022-08-13
Journal: PLoS ONE [Category] Biochemistry, 진단, 치료기술,

[키워드] activated acute disease acute respiratory syndrome acute respiratory syndrome coronavirus antibody antibody-secreting plasmablasts B cell B cell response B cell responses B cell subsets causative agent CD24 CD27 characterized classical Clinical outcome composed convalescent Convalescent patients convalescent plasma treatment Coronavirus-2 correlated COVID-19 Critical disease Donor donors duration of symptom enrolled expansion Frequency health emergency identify IGD IgG1 IgM IgM response IgM responses memory memory B cell memory B cells pandemic Peripheral blood plasma antibody positive RBD Receptor binding domain remained respiratory Respiratory illness response responses SARS-CoV-2 SARS-CoV-2 immunity SARS-CoV-2 spike protein receptor binding domain seropositive subjects Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 significant negative correlation significantly Spike protein subject subjects subset symptom duration the SARS-CoV-2 while
[DOI] 10.1371/journal.pone.0244855 PMC 바로가기 [Article Type] Research Article

COVID-19 Response in Thailand and Its Implications on Future Preparedness

Article

Published on 2021-01-262022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, MERS,